Susan Hasty, Publisher
Table of Contents . . . October 24th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Immunotherapy Weekly | Other Publications
Tuberculosis Survival and Mortality - Interferon-(gamma) Restrains Immune Response
Vaccine Delivery - Coimmunization Leads To Immune Response In Woodchuck Hepatitis Model
Autism - Behavior Linked To Brain Areas With Tuberous Sclerosis
Fertility - 'Master' Stress Hormone Prevents Mother From Rejecting Embryo
HIV Vaccines - Canarypox-Based Vaccines Trigger (gamma) {{delta}} T-Cell Activity
Pathogenesis - Researchers Discover Possible Trigger For T-Cell Attack
AIDS Therapies - Viral Control After Early Antiretroviral Treatment May Guide Vaccine Research
Adenovirus Vaccines - Barr Awarded $35 Million Department Of Defense Contract
Allergy Medicine - New Yorkers With Lung Disease Use Caution In Lower Manhattan
Allergy Medicine - Patient Trials Of CAT-213 Start In United Kingdom
Allogeneic Transplantation - BioTransplant Gets CE Mark for Second HDM Cell Separation Product
Appointments - Immunomedics Names Chief Financial officer
Asthma - Children With Asthma Participate In Olympic-Style Games
Asthma - New National Program Aims To Reduce Hospital Visits By Children
Collaborations - AlleCure Announces Alliance With BD Biosciences
Conference News - Engineered Antibodies Accelerating Drug Discovery And Development Conference Rescheduled
Deals - Actimmune Manufacture Transferred To Boehringer Ingelheim
Finance - Protalex Completes Private Placement, Comments On PreClinical Studies
Graft-Versus-Host Disease - Phase III Drug Candidate Receives Orphan Drug Designation
Huntington Disease - Advance In The Molecular Pathology Reported
Multiple Sclerosis - New Study Explains Discrepancies In TNF-(alpha) Behavior
Neurology - Neuroimmunophilin Ligand Program Returned To Guilford Pharmaceuticals
Pediatric Cardiology - FDA Removes Clinical Hold From Avant's TP10 Phase IIb Studies
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.